Abstract: Of late, many studies are attempting to find new molecules with anticancer properties, especially those with the capability to inhibit cell growth. The aim of this work was to evaluate nerolidol, a plant-based compound, as its cytotoxicity, genotoxicity, antiproliferative and apoptotic induction, cell cycle, mitochondrial membrane potential and RT-qPCR of transcripts related to those pathways in the human hepatocellular carcinoma cell line (HepG2/C3A). Only cis-nerolidol (C-NER) demonstrated cytotoxicity (100-250 lM) activity and was selected to conduct the following experiments. C-NER did not show genotoxic activity, but altered the mitochondrial membrane potential, reduced cell proliferation by arresting cell cycle in G1 phase and induced cell death. RT-qPCR showed that C-NER down-regulated genes related to apoptosis (BAK1, BAX, CAPN1, CASP8, CASP9, PARP1 and TP53), cell cycle (CCND1, CCNE1, CDK1 and CDK2), xenobiotic metabolism (CYP2D6 and CYP3A4) and paraptosis (IGF1R receptor). Up-regulation was seen in case of genes related to cell survival (BBC3 and MYC) and reticulum stress protein response (EIF2AK3 and ERN1) and xenobiotic metabolism (CYP1A2 and CYP2C19). We deduced that the antiproliferative activity of C-NER is attributable to its modulation of the cyclins and cyclin-dependent kinases as these proteins are necessary for G1/S phase transition. EIF2AK3, ERN1, CYP2C19 and CYP1A2 up-regulation suggests that endoplasmic reticulum stress was induced owing to the increased activity of cytochrome P450 enzymes. Caspase-independent cell death was also observed, indicating that another type of cell death, paraptosis, was triggered. Our results indicate that C-NER has considerable potential in anticancer therapy because it modulates important molecular targets of cell survival and proliferation.
Naturally occurring compounds are an important resource for studies investigating potential therapeutic drugs. In particular, the need for developing new drugs with anticancer potential has led to increased attempts in finding natural molecules with antiproliferative capabilities. Several phytochemicals that confer anticancer effects have been reported, including those that target NF-jB (alantolactone and xanthohumol), caspases (goniothalamin, corosolic acid and pyranocycloartobiloxanthone), AP-1 (curcumin, quercitrin and parthenolide), cell cycle proteins (rhodoxanthin and capsaicin) and reactive oxygen species (eugenol, gallic acid and piperlongumine) [1] . In this context, nerolidol -a compound found in many plant species -has attracted considerable attention in various research fields owing to its anti-inflammatory [2] , antileishmanial [3] and antifungal [4, 5] activities. Nerolidol is a sesquiterpene (C 15 H 26 O) and occurs in the form of two isomers -cis-nerolidol (C-NER) and trans-nerolidol (T-NER) [6] .
The cell cycle is one of the most important processes responsible for normal physiological functioning. In cancer, irregularities in cell division or death may lead to abnormal cell growth, ultimately causing tumour formation. The cell cycle is tightly regulated by control mechanisms, labelled cell cycle checkpoints, which mediate the G1/S, S and G2/M phase transitions. These checkpoints prevent perturbations that may interrupt the cell cycle and involve proteins such as cyclin-dependent kinases (CDKs) and cyclins [7] [8] [9] .
Molecular biology tools such as cell culture have considerably advanced discovery of compounds with anticancer properties and have helped clarify the molecular mechanisms of action of these compounds. Cell cycle-control genes and their products such as cyclins and CDKs -in addition to those involved in unfolded protein response such as ERN1 and HSPA5 -are important drug targets that are studied in assessing the biological activity of anticancer compounds. The cell line used in this work, HepG2/C3A, is a human hepatocellular carcinoma cell line, which is widely used in genotoxicity studies because it expresses proteins related to xenobiotic metabolism [10, 11] , which is an important parameter for studying drug toxicity.
Accumulating lines of evidence have recently indicated that targeting cell signalling pathways may be promising in developing potential therapeutic drugs. These signalling pathways involve cell cycle, unfolded protein response, xenobiotic metabolism and cell death and may play crucial roles in cancer chemoprevention. Some natural compounds of plant origin, such as curcumin, resveratrol, paclitaxel and quercetin, can induce cell death and are considered potential therapeutic agents to neutralize the effects of carcinogens [12] .
Programmed cell death generally occurs through apoptosis, which is actively executed by specific proteases and caspases, while coagulative necrosis is a type of accidental cell death caused by ischaemia or infarction. Newer evidence indicates that programmed cell death can occur independent of or in the absence of caspase activation. Alternative models of programmed cell death (PCD) have therefore been proposed, including autophagy, paraptosis, mitotic catastrophe and the descriptive model of apoptosis-like and necrosis-like cell death [13] .
Safe and toxic exposure levels of naturally occurring compounds with anticancer effects need to be ascertained before they are used in cancer therapy. Few compounds show wellknown toxicity profiles, and drug candidates include several distinct chemical classes as determined using in vitro toxicology methods [14] . Compounds that target detrimental physiological effects of cell cycle arrest, endoplasmic reticulum stress, aberrant drug metabolism and hampered cell death in cancer cells, rather than their individual gene or protein components, have significant potential in cancer treatments [15] .
Understanding the mechanism of action of natural plant products in inducing cell death in cancer cells is essential for searching lead molecules in the field of cancer chemoprevention. We used parameters such as cytotoxicity, cell death and proliferation, and xenobiotic metabolism in morphological and molecular evaluation of anticancer properties of nerolidol, in addition to elucidating its mechanism of action in the human hepatocellular carcinoma cell line (HepG2/C3A).
Material and Methods
Chemical agents. C-NER, T-NER and a mix of both (M-NER) were purchased from Sigma-Aldrich (cat. no. 72180, 18143 and H59605) and were diluted in ultrapure water.
Cell culture. HepG2/C3A cells, free of mycoplasma, were obtained from the Rio de Janeiro Cell Bank. The cells were maintained in Dulbecco's modified Eagle's medium (DMEM; Gibco) with pyruvate and L-glutamine (Catalogue No. 11995-081), supplemented with 10% foetal bovine serum (FBS) (Gibco) and 0.1% penicillin-streptomycin (Gibco). The cells were maintained in a humidified incubator with 5% CO 2 at 37°C. In these conditions, the duration of cell cycle is approximately 24 hr. The cells were cultured for 24 hr after being plated for stabilization for all experiments. The proper number of cells to be used in the experiments was determined using the xCELLigence real-time cell analysis system. The cell number and media volume were adjusted according to the volume of the flasks used. All assays were performed in three biological replicates.
Cytotoxicity
analysis. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay (cat. no. M-6494, Invitrogen) was used to evaluate the cytotoxicity of C-NER, T-NER and M-NER at concentrations of 0, 100, 150, 200 and 250 lM. The MTT assay assesses the viability and the metabolic state of the cells [16] . MTT is metabolized by dehydrogenase and reductase enzymes, and the product (formazan) is quantified colorimetrically. The cells (25 9 10³) were seeded in 96-well culture plates for 24 hr of treatment. Then, the culture media were removed and 100 lL of culture medium without FBS but with 0.5 mg/mL of MTT) was added. After 4 hr of incubation, the culture medium was removed, and formazan crystals adhering to the bottoms of the wells were diluted in 100 lL of dimethyl sulphoxide for checking the absorbance at 540 nm. Cell survival ratio was estimated by dividing the treatment absorbance value by the control (0 lM treatment) absorbance value and multiplying by 100.
Real-time cell index profiling. This assay was used to determine the cell survival index by using the xCELLigence real-time cell analysis single-plate instrument (Roche Diagnostics GmbH, Mannheim, Germany) for a 96-hr treatment of C-NER. In 96-well plates, 25 9 10³ cells were seeded and the cell index was monitored every 30 min. by using eight replicates per treatment. Because only C-NER demonstrated cytotoxicity in the MTT assay, only C-NER was used from this point at concentrations of 0, 25, 50, 100, 150, 175, 200, 250, 275, 300 and 350 lM.
Estimation of mitochondrial membrane potential (Dw mit ) using rhodamine 123. Rhodamine 123 is a fluorescent dye used to measure mitochondrial membrane potential, which accumulates inside healthy mitochondria depending on its electrical activity [17] . In total, 617 9 10³ cells/well were seeded in six-well plates. After 24 hr of treatment with 0, 50, 100, 200, 250 and 275 lM of C-NER, 2 lL of rhodamine 123 (1 mg/mL) was added to each well, and the plates were incubated for 30 min. Then, the cells were harvested and centrifuged at 644 g for 5 min. and were resuspended in 800 lL of PBS. For flow cytometry, 5000 cells were analysed with a red filter to measure mean fluorescence of the cells.
Comet assay. Comet assay [18, 19] was used to analyse the potential of C-NER in damaging genetic material. In total, 617 9 10³ cells were seeded in each well in a six-well plate. After 3 hr of treatment with C-NER at concentrations of 0, 100 and 150 lM, the cells were trypsinized, centrifuged at 644 g for 5 min. and resuspended in 50 lL of culture medium. Then, the cells were diluted in 0.5% low-melting point agarose and distributed on pre-gelatinized slides with common agarose. The cells were lysed (2.25 M NaCl, 90 mM EDTA, 9 mM Tris-HCl, 10% dimethyl sulphoxide and 1% Triton X-100) for 60 min. at 4°C and were then exposed to alkaline conditions (electrophoresis buffer: 1 mM EDTA [Titriplex] and 0.3 N NaOH) for 20 min. Electrophoresis was performed at 25 V and 300 mA for 20 min. at pH 13. Subsequently, the slides were neutralized (Tris buffer; pH 7.5 adjusted with 0.4 N HCl), fixed with absolute ethanol (PA) and stored at 4°C. The analysis was performed with 100 lL of a solution containing ethidium bromide (2 lg/mL) to stain the DNA. Micrographs were obtained using the EVOS â Microscope FL Auto Cell Imaging System (Thermo Fisher) at a magnification of 2009. For comet assay, images were analysed using the CometScore© program to evaluate the parameters of comet length and tail length.
Cell cycle analysis. In total, 617 9 10³ cells/well were seeded in six-well plates. After 12 and 24 hr of treatment with C-NER concentrations of 0, 150 and 250 lM, the cells were harvested, centrifuged at 644 g for 5 min. and resuspended in 100 lL of PBS. Next, 0.1 mg RNase A (cat no. 12091-021, Thermo Fisher Scientific) was added, and the cells were incubated at 37°C for 30 min.
Subsequently, lysis and labelling of DNA were completed using 100 lL of HFS solution (50 lg/L propidium iodide, 0.1% sodium citrate, 0.1% Triton X-100), and the resultant product was incubated on ice for 30 min. and protected from light. The fluorescence of propidium iodide was estimated with Guava EasyCyte (Merck Millipore) flow cytometer analysing 5000 cells/treatment. The DNA content was estimated and the percentage of cells in different phases of cell cycle (G1, S and G2/M) was estimated according to the fluorescence intensity.
Apoptosis assay. Flow cytometry (Guava EasyCyte, Merck Millipore) was performed to verify whether the C-NER treatments induced apoptosis in the cells. In six-well plates, 617 9 10³ cells/well were seeded. After 12 and 24 hr of treatment, the cells were trypsinized, centrifuged at 644 g for 5 min. and resuspended in 100 lL of PBS. Next, the cells were labelled using BD Pharmingen Annexin V PE Apoptosis Detection Kit (cat. no. 550914; BD Biosciences) according to the manufacturer's recommendations. The cells were considered viable when not labelled with annexin and 7-AAD (7-Aminoactinomycin D). The cells labelled with annexin but not with 7-AAD were considered to be undergoing early apoptosis; the cells labelled with annexin and 7-AAD were considered to be undergoing late apoptosis; and those labelled only with 7-AAD were considered necrotic.
RT-qPCR. RT-qPCR was performed to examine changes in gene expression patterns. Table S1 contains a list of primers used to amplify genes involved in the cell cycle (CCND1, CCNE1, CDK1, CDK2, CDKN1A and TP53), endoplasmic reticulum stress (ERN1, EIF2AK3 and HSPA5), apoptosis (BAK1, BAX, CASP3, CASP7, CASP8, CASP9 and PARP1), xenobiotic metabolism (CYP1A2, CYP2C19, CYP2D6 and CYP3A4), cell survival (MYC and BBC3) and paraptosis marker (IGF1R). In total, 617 9 10³ cells/well were seeded in six-well plates. Total RNA was extracted using RNeasy Kit (cat. no. 74106; Qiagen) after exposure (6 and 12 hr) to C-NER treatments (0, 150 and 250 lM concentrations). The samples were quantified using a spectrophotometer. RNA purity was estimated based on the ratio of absorbance at 260 nm/280 nm, and only samples with a ratio between 1.8 and 2.1 were used for further experiments. RNA integrity was assessed using denaturing agarose gel electrophoresis (1% agarose). cDNA synthesis was performed with 500 ng of total RNA in a final reaction volume of 20 lL. [12] [13] [14] [15] [16] [17] [18] , random primers and dNTPs was used for a pre-incubation step of 10 min. at 65°C in a T100 ™ Thermal Cycler (Bio-Rad), followed by heat shock at À20°C.
A second mixture containing the remaining constituents was prepared and added to the initial mixture, yielding a total reaction volume of 20 lL. The reaction mixture was then used for the following thermocycling program: 37°C for 50 min. and 70°C for 15 min., with a lid temperature of 105°C. cDNA synthesis reactions were performed in triplicate, and the products were mixed to form a single sample. The cDNA was quantified and diluted to a concentration of 50 ng/lL for use in qPCR. The real-time reaction was performed with the CFX96 Touch Statistical analysis. Each assay was performed in three replicates. Statistical analysis was performed with analysis of variance (ANOVA) with Dunnett's post-test. RT-qPCR data were analysed using the REST program, and a significant difference was considered when relative gene expression level was ≤0.5 or ≥2. Efficiency of the reactions was calculated using the program LinRegPCR. For all tests, the differences were considered statistically significant at a p-value of ≤0.05.
Results
The MTT assay showed that neither T-NER on its own nor when mixed with C-NER conferred any cytotoxic effect at the tested concentrations. By contrast, C-NER on its own reduced cell viability from 89% to 3% in a dose-dependent manner, at concentrations of 100-250 lM ( fig. 1) . Therefore, C-NER was selected for further experiments.
Real-time cell analysis showed that C-NER altered cell survival curve in a dose-dependent manner in comparison with the control treatment ( fig. 2 ). C-NER concentrations of 25-100 lM produced a response similar to that of the control; however, the cell index decreased after 60 hr of treatment. C-NER concentration of 150-200 lM showed a significant initial decrease in cell index, followed by a significant increase when compared with the control; this effect is likely attributable to the morphological changes caused by C-NER considering this assay produced a cell index measurement based on the electric impedance of the cells. C-NER concentration of 250-350 lM showed reduced cell index immediately after the initial hours.
Mitochondrial membrane potential was also altered by C-NER treatment, increasing at 50 lM and decreasing at 200-275 lM ( fig. 3) .
Comet assay did not show any difference in C-NER treatment when compared with control for all analysed parameters ( fig. 4 ). However, cell count was reduced for C-NER concentration of 150 and 250 lM when compared with control, 12 and 24 hr after treatments ( fig. 5) .
Cell cycle analysis showed that C-NER treatment caused G1 arrest in HepG2/C3A cells after 12 hr of treatment, but only at a concentration of 150 lM. After 24 hr of treatment, there was an increase in the number of cells with G1 arrest at 150 and 250 lM of concentration, with the percentages of G1 cells at 48.97% for the control group, and 60.32% and 60.46% for those treated with 150 and 250 lM C-NER ( fig. 6 ).
Apoptosis analysis by flow cytometry showed that C-NER induced significant cell death only at a concentration of 250 lM (table 1). After 12 hr of treatment, C-NER treatment increased the percentage of cells undergoing early apoptosis (19.47%) and necrosis (2.39%) when compared with control (11.54 and 0.61%, respectively). After 24 hr of exposure, there was a significant increase in cells undergoing early (12.07%) and late apoptosis (5.39%) and necrosis (7.45%) when compared with control (4.95, 2.56 and 0.52%, respectively). Figure 7 shows gene expression analysis by RT-qPCR. In general, the response was bigger for higher dose and time treatment of C-NER. Most of the significantly altered transcripts (Table S2) were down-regulated (BAK1, BAX, CASP8, CASP9, CCND1, CCNE1, CDK1, CDK2, CYP2D6, CYP3A4, IGF1R, PARP1 and TP53), but a few were significantly upregulated (BBC3, CYP1A2, CYP2C19, EIF2AK3, ERN1 and MYC).
Discussion
Although many biological activities of nerolidol have been demonstrated [2, 3, 20] , it is still necessary to keep testing the compound in response to a considerable need to study new drugs with antiproliferative properties. Our results showed that C-NER possesses higher cytotoxic potential than do T-NER and M-NER. Ambroz and Bousova [21] showed that T-NER at a concentration of 10 lg/mL or more (4488-2244 lM) reduces cell viability after 96 hr of treatment in Caco-2 cells. T-NER at a concentration of 10-100 lM is cytotoxic to HepG2 cells after 24 and 48 hr of treatment (10-100 lM), affecting mitochondrial and cellular energetics [20] . We did not observe T-NER cytotoxicity at those concentrations, probably because we evaluated only at 24 hr of treatment and differences in physiological characteristics of the tested cell lines.
We identified the antiproliferative potential of C-NER and suggest that this effect was caused by its ability to inhibit cell growth at G1 phase and induce cell death. G1 phase proteins such as CDK1, CDK2, CCND1 and CCNE1 were transcriptionally reduced, and their absence may have caused the cell cycle disturbance. This highlights the potential of C-NER to be used as an antiproliferative drug, and to be further studied for use in cancer therapy [22] [23] [24] . TP53 encodes the tumour suppressor protein p53, which regulates cell cycle via transcriptional activation of several genes, including CDKN1A -a CDK inhibitor [25, 26] . We observed a significant reduction in TP53 expression after treatment with 250-lM C-NER after 12 hr; however, CDKN1A expression remained unchanged, suggesting that the cell cycle disruption observed in the present study was not modulated by this gene. Another cell cycle and proliferation regulator, PARP1, showed decreased expression induced by C-NER at both concentrations and all the times tested. PARP1 encodes a chromatin-associated enzyme that is overexpressed in many cancers, suggesting that C-NER may be an important target-specific drug to be used in treating those types of diseases [27, 28] .
At high doses (equal or greater than 250 mg/kg of bodyweight), nerolidol induces genotoxic damage in the peripheral blood cells after 4 and 24 hr of treatment in male Swiss mice, in addition to their liver after 24 hr of treatment, along with mutagenic activity in bone marrow cells after 24 hr [29] . However, our comet assay results show that the cytotoxicity of C-NER seems not to be related to its genotoxicity but to mitochondrial and endoplasmic reticulum (ER) stress by the altering mitochondrial membrane potential and up-regulating ERN1 and EIF2AK3.
ERN1 encodes an ER-resident transmembrane sensor, which identifies misfolded proteins in order for them to be degraded, and a transcript factor for genes involved in ER stress signalling (UPR genes). EIF2AK3 also encodes a misfolding protein stress sensor in ER, which inhibits translational activity to minimize ER stress [30] . ER stress has been already reported to cause G1 phase arrest [31, 32] as identified in our present study.
Our data show that most of the genes showed altered expression after 12 hr of C-NER treatment, although a few genes were already affected at 6 hr. Key genes involved in G1 arrest (CCND1 and CDK1), ER stress (ERN1 and EIF2AK3) and cell survival (BAK1, BBC3, MYC, and PARP1) were transcriptionally modulated right after 6 hr of C-NER treatment. This suggests that the molecular and morphological changes identified in our study may be correlated to those key genes. MYC encodes an important transcription factor that regulates expression of many genes, including cyclin D (CCND1) during G0 to S transition [33] . Although the absence of MYC causes G1 arrest, we observed an up-regulation of MYC, which appears to be related to ER stress and cell death signalling as discussed below. MYC up-regulation is associated with EIF2S1 expression [34] , which encodes a protein that is required in ER stress signalling via EIF2AK3 [30, 35] , which was also up-regulated in response to C-NER.
Apoptosis assay showed an increase in annexin/7-AAD binding only at C-NER concentration of 250 lM, but Initiators of apoptosis, caspases 8 and 9, were transcriptionally reduced, but effector caspases 3 and 7 remained intact. Expression of pro-apoptotic genes, BAK1 and BAX, was also reduced. This shows that programmed cell death was induced by C-NER in a caspase-independent manner, considering that it was not followed by an increase in caspases transcripts. Sperandio and de Belle [36] describe paraptosis -an alternative mode of programmed cell death independent of caspases, which is followed by swelling of mitochondria and endoplasmic reticulum. Paraptosis, the swelling of vesicles, and, consequently, cellular swelling may explain the increase in cell index observed after the initial hours of C-NER treatment in our proliferation assay. Cell survival index is determined not only by cell number, but also by cell morphology, and fig. 8 shows the appearance of cytoplasmic agglomerates after 250 lM C-NER treatment. Phosphatidylserine bound by annexin observed in 250 lM treatment can be related to the fact that phosphatidylserine externalization may occur in paraptosis [37] and detected by this label.
Insulin-like growth factor 1 receptor (IGF1R) has been described to induce paraptosis mediated by CASP9 [36] ; however, we identified reduced IGF1R gene transcripts for the highest C-NER concentration at both analysed times, and reduced CASP9 transcripts for higher C-NER concentration after 12 hr of treatment.
Puma, a pro-apoptotic protein coded by BBC3, is related to caspase-independent cell death [38, 39] and was increased after C-NER treatment after 6 and 12 hr, corroborating the caspaseindependent cell death.
Gene expression analysis by qPCR detected an increase in cytochrome P450 transcripts of CYP2C19 and CYP1A2, suggesting that C-NER underwent chemical modifications by these enzymes. Drug metabolism is directly related to its toxicity because it gives information about its pharmacological properties. Chemical modifications made in drug metabolism can reduce or increase compound toxicity depending on a range of factors such as individual polymorphisms and drug half-life [40] . Cytochrome P450 enzymes are present in ER membrane, and it is reported that extensive metabolism of toxic drugs can induce ER stress [41] [42] [43] .
Here, we propose that C-NER is extensively oxidized by CYP2C19 and CYP1A2 enzymes present in the ER, causing ER stress. The misfolding proteins formed in a stressed ER flagged the transcriptional activation of ER stress sensors ERN1 and EIF2AK3, which trigger cell cycle disruption and death. As the other forms of nerolidol did not induce any cytotoxicity, it is clear that C-NER is responsible for the antiproliferative properties we observed. Further pre-clinical studies must be performed to confirm C-NER's antiproliferative activity in other biological models in order to verify its anticancer properties, especially using in vivo techniques and in non-tumour cells to predict its side effects. Fig. 8 . Photomicrograph (4009) of C3A cell culture in control (A) and C-NER 250 lM (B) after 24 hr of treatment. The formed agglomerates are indicated by the red arrows. Photomicrographs were obtained using EVOS â Microscope FL Auto Cell Imaging System (Thermo Fisher).
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